7069-42-3

Basic information

• Product Name: RETINYL PROPIONATE
• Synonyms: ALL TRANS-RETINOL PROPIONATE;RETINYL PROPIONATE;VITAMIN A PROPIONATE;Retinol,propanoate;VITAMIN-A-PROPIONATE, ~2500 U/MG*;VITAMIN-A-PROPIONATE 2500 U MG 98+%;Retinylpropionat;Propanoic acid (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexene-1-yl)-2,4,6,8-nonatetrenyl ester
• CAS NO: 7069-42-3
• Molecular Formula: C₂₃H₃₄O₂
• Molecular Weight: 342.51
• EINECS: 230-363-2
• Product Categories: Intermediates & Fine Chemicals;Pharmaceuticals;Retinoids;supplement
• Mol File: 7069-42-3.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 501.8°C at 760 mmHg
• Flash Point: 128 °C
• Appearance: /
• Density: 1.01g/cm³
• Vapor Pressure: 3.36E-10mmHg at 25°C
• Refractive Index: 1.534
• Storage Temp.: 2-8°C
• Solubility: Chloroform (Slightly), DMSO (Slightly), Ethyl Acetate (Slightly)
• Stability: Light Sensitive
• BRN: 2475675
• CAS DataBase Reference: RETINYL PROPIONATE(CAS DataBase Reference)
• NIST Chemistry Reference: RETINYL PROPIONATE(7069-42-3)
• EPA Substance Registry System: RETINYL PROPIONATE(7069-42-3)

Safety Data

• Hazard Codes: Xn,T
• Statements: 38-63-53-61
• Safety Statements: 53-45
• WGK Germany: 1
• F: 1-8-10
• Hazardous Substances Data: 7069-42-3(Hazardous Substances Data)

Usage

Description

Retinyl Propionate is a Vitamin A ester derivative, known for its hypermitotic properties. It is a compound that contains an unknown cis isomer and is widely recognized for its beneficial effects in cosmetic formulations.

Uses

Used in Cosmetic Industry:
Retinyl Propionate is used as a hypermitotic agent for promoting skin cell turnover and enhancing the overall health and appearance of the skin. Its presence in cosmetic formulations helps improve skin texture, reduce the appearance of fine lines and wrinkles, and provide a more youthful and radiant complexion.

InChI:InChI=1/C23H32O3/c1-7-21(24)26-22(25)16-18(3)11-8-10-17(2)13-14-20-19(4)12-9-15-23(20,5)6/h8,10-11,13-14,16H,7,9,12,15H2,1-6H3/b11-8+,14-13+,17-10+,18-16+

Upstream product

• 55497-41-1 3-methyl-2-((2,6,6-trimethylcyclohex-1-en-1-yl)methyl)-2,5-dihydrothiophene 1,1-dioxide 
• 14919-02-9 4-propionyloxy-2-methyl-2-buten-1-al 
• 13832-89-8 (2E,4E,6Z)-3,7,11-Trimethyl-dodeca-2,4,6,10-tetraenal 
• 80442-43-9 (2E)-farnesal 
• 82010-11-5 farnesyl alcohol 
• 68-26-8 RETINOL 
• 802294-64-0 propionic acid 

Downstream Products

• 302-79-4 all-trans-retinoic-acid 
• 81121-20-2 4-methoxyretinoic acid 

Relevant articles and documents

PROCESS FOR PRODUCTION OF NEW SULFOLENIC INTERMEDIATES

The present invention relates to a new process for the production of new specific intermediates, which are preferably used in the production of vitamin A, vitamin A acetate, or β-carotene and derivatives thereof, e.g. canthaxanthin, astaxanthin or zeaxanthin.

Method for preparing vitamin A and vitamin A ester

The invention provides a novel method for preparing vitamin A and vitamin A ester by taking farnesol as a raw material. The method comprises the following steps: carrying out oxidation reaction on farnesol and oxygen under the action of a catalyst and a cocatalyst to generate farnesal; carrying out dehydrogenation reaction on farnesal to generate dehydrofarnesal; carrying out cyclization reactionon the dehydrofarnesal under the catalysis of acid to generate a cyclized intermediate; carrying out a reaction on the cyclized intermediate with chloroisopentenol to generate vitamin A; carrying outan esterification reaction on vitamin A to generate vitamin A ester. The method avoids the defects of an existing process, and the process line is economical and effective.